Errors in Figures

Дата публикации: 01-07-2026 00:00:00

The Original Investigation titled “PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-Analysis,” published online on June 4, 2026, included errors in a data point in Figure 1 and citations in Figures 1 and 3. In Figure 1A, the upper bound of the 95% CI for the hazard ratio corresponding to the third study from the top, Zhong et al, was changed from 1.75 to 1.90. Also in Figure 1A, the citation in the last study listed, Lu et al, was changed from reference number 33 to 32. In Figure 3A, the citation in the first row, Zhou et al, was changed from reference number 17 to 16. This article has been corrected online.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Error in Supplement 3	0	19.38	01-10-2026
2	Error in Byline	0	12.93	01-07-2026
3	Pathological response and exploratory assessment of pretreatment PD-L1 combined positive score after four cycles of neoadjuvant pembrolizumab plus chemotherapy in locally advanced head and neck squamous cell carcinoma: a retrospective cohort study	0	13.96	07-08-2026
4	Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer	0	7.57	01-07-2026
5	Pretreatment prognostic nutritional index is associated with survival outcomes in locally advanced NSCLC treated with definitive chemoradiotherapy	0	5	17-07-2026
6	Treatment Dependent Response Modeling Using Morphologic and Qualitative Features from Perfusion and Contrast-Enhanced Susceptibility Imaging in Undifferentiated Pleomorphic Sarcoma: A Comparison of Radiation Alone Versus Consecutive Chemotherapy and Radiation	0	13.58	07-08-2026
7	Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into More Inflamed Tumours and Improve Response	0	37.27	03-08-2026
8	Should Risk of Bias Be Assessed at the Outcome Level?	0	8.24	01-07-2026
9	Serum and Tumor PD-L1 Expression and Aggressive Clinicopathologic Features in Papillary Thyroid Carcinoma	0	12.37	13-08-2026
10	Exosome-Mediated Communication in The Tumor Microenvironment: Mechanism and Therapeutic Challenges [version 1; peer review: awaiting peer review]	0	14.4	06-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.94. Источник: jamanetwork.com.